Sign in

You're signed outSign in or to get full access.

Jay Richards

Chief Risk Officer of BankUnited, N.A. at BankUnitedBankUnited
Executive

About Jay Richards

Jay D. Richards is Chief Risk Officer (CRO) of BankUnited, N.A., a role he has held since September 2019; he previously served as Chief Credit Officer from January 2018 to September 2019. He has a B.S. in Finance from Indiana State University and is 54 years old . Under his tenure as CRO, BankUnited highlighted improving profitability in 2024: net income of $232.5 million ($3.08 diluted EPS), ROAE of 8.5%, and ROAA of 0.66% for FY 2024, with quarterly trends in EPS, NIM, ROAA and ROAE improving through the year .

Past Roles

OrganizationRoleYearsStrategic impact
BankUnited, N.A.Chief Risk OfficerSep 2019–presentLed ERM consolidation; oversight of risk culture, regulatory relations, ACL oversight, asset quality maintenance .
BankUnited, N.A.Chief Credit OfficerJan 2018–Sep 2019Credit risk leadership prior to ERM consolidation .
TD Bank (and predecessors)Senior leadership roles2008–2018Experience across capital markets, C&I, CRE, consumer, specialty banking; M&A diligence/integration .
Compass BankSenior leadership role2006–2008Credit/risk and banking leadership .
Regions Bank (and predecessors)Senior leadership roles1999–2006Credit/risk leadership across business lines .
Bank One (JPMorgan Chase)Early career roles1993–1999Foundational experience across banking and workout/recovery .

External Roles

OrganizationRoleYearsNotes
No external directorships or public company board roles disclosed in Mr. Richards’ biography in the proxy .

Fixed Compensation

YearBase salary ($)All other compensation ($)Notes
2024425,000 15,525 (401(k) contribution) No 2024 base salary changes for NEOs; CRO listed at $425k .
2023420,833 14,850
2022400,000 13,725
  • Deferred comp: Mr. Richards does not participate in the Nonqualified Deferred Compensation Plan .
  • Pension/SERP: Company has no defined benefit pension plans .
  • Perquisites: None disclosed for Richards beyond standard benefits; no excise tax gross-ups company-wide .

Performance Compensation

Annual incentive (cash)

Performance yearAward ($)StructureKey evaluation criteriaApproval date
2024400,000 Discretionary under Company’s Policy on Incentive Compensation Arrangements (separate from NEO AIP to preserve CRO independence) Risk culture program, enterprise-wide RCSA framework, enhancements to risk assessment, regulatory relations, portfolio concentrations/performance reporting, acceptable asset quality, ACL oversight/challenge Feb 19, 2025
2023350,000 Discretionary per policy Executing ERM/Credit governance; sound frameworks; rating system; balanced risk culture Feb 21, 2024
2022375,000 Discretionary per policyCompany policy-driven evaluation of contributions and responsibilities
  • Unlike other NEOs, Richards does not participate in the formulaic AIP tied 75% to financial metrics and 25% to strategic objectives, to avoid misaligned incentives for the CRO .

Equity awards (restricted shares)

Grant dateTypeShares (#)Grant-date fair value ($)Vesting schedule
Mar 1, 2025Restricted shares (RSA)13,500 — (to be reported in 2026 proxy) 25% on each of Mar 1, 2026/2027/2028/2029, subject to service .
Mar 1, 2024Restricted shares (RSA)13,000 340,990 Equal annual installments on Mar 1, 2025/2026/2027/2028, subject to service; participates in dividends .
HistoricalRestricted shares (RSA)Included in outstanding totalsSee “Vesting schedule” below .

Vesting and realized shares:

  • 2024 vesting: 12,250 restricted shares vested; value realized $321,318 .
  • Outstanding at Dec 31, 2024: 31,750 unvested RSAs (12,500 vested on Mar 1, 2025; 9,500 vest Mar 1, 2026; 6,500 on Mar 1, 2027; 3,250 on Mar 1, 2028) .

Equity Ownership & Alignment

As ofBeneficial ownership (shares)% of shares outstandingNotes
Mar 25, 202543,135 ~0.06% (43,135 / 75,242,048) Footnote indicates restricted shares included; anti-pledging/hedging policy applies .
Mar 18, 202447,330 Includes restricted shares; change vs 2025 likely reflects net share settlement on vesting .

Stock ownership guidelines and compliance:

  • Requirement: 3x base salary for NEOs; Richards required to hold ~$1,275,000 and is in compliance (based on policy ratification and $28.00 stock price as of Mar 28, 2024) ; reaffirmed as “Yes” in Feb 2025 policy ratification .
  • Anti-hedging/anti-pledging: Executives are prohibited from pledging company securities or engaging in hedging transactions; no margin accounts .
  • Clawback: Company maintains an NYSE/SEC-compliant compensation recovery policy for restatements; excess incentive-based comp must be recouped .

Near-term vesting/selling pressure:

  • Upcoming vest tranches: 9,500 shares (Mar 1, 2026), 6,500 (Mar 1, 2027), 3,250 (Mar 1, 2028) from 2024 grant, plus 3,375 per year from the 2025 grant (Mar 1, 2026–2029) subject to service .
  • Company’s executive ownership policy restricts sales if holdings would fall below guideline thresholds .

Employment Terms

Severance and change-in-control (CIC) economics (current policy basis, 2024 year-end assumptions):

ScenarioCash severanceContinued benefitsEquity accelerationNotes/Trigger
Termination without cause / for good reason (following CIC)1,211,898 Double-trigger equity acceleration within 24 months post-CIC; assumed cash-out valuation at $38.17 .
Change in control (no termination)Equity awards assumed/continued; no single-trigger vesting (other than CEO program) .
  • Company-wide equity treatment: If awards are assumed at CIC, no acceleration at closing; acceleration occurs only upon qualifying termination within 24 months (double-trigger) .
  • Historical note (at hire): Richards had a CIC agreement (commenced Jan 29, 2018) that paid lump sums equal to 3x/2x/1x base salary if CIC occurred within first three years of employment; subsequent proxies reflect current limited severance framework with no cash multiple for Richards .
  • Clawback and insider trading controls as noted above .

Performance & Track Record

  • 2024 contribution highlights used in evaluation and award: developed risk awareness culture, implemented enterprise-wide RCSA, enhanced risk assessment framework, maintained strong regulatory relationships, monitored portfolio concentrations/performance, maintained acceptable asset quality, and provided ACL oversight/effective challenge .
  • Company performance context: In 2024, EPS, NIM, ROAA, ROAE improved sequentially; funding mix improved (NIDDA 27.3%; wholesale funding ratio 23.4%), while relative NPA metric did not pay out for other NEOs’ AIP program; CRO remained on separate discretionary program to preserve independence .

Company Financial Context (tenure backdrop)

MetricFY 2019FY 2020FY 2021FY 2022FY 2023FY 2024
Revenues ($)147,204,000*133,221,000*134,153,000*77,636,000*86,838,000*99,155,000*

Values retrieved from S&P Global.

Compensation Structure Analysis (signals)

  • Mix and risk: CRO does not participate in formulaic AIP or PSUs; cash incentive is discretionary under a risk-balanced policy, reducing potential for risk-taking tied to earnings metrics; equity awards are time-based RSAs with 4-year ratable vesting, aligning retention and long-term orientation .
  • Governance alignment: No excise tax gross-ups; anti-hedging/anti-pledging; robust clawback; executive stock ownership policy with compliance confirmed for Richards .
  • CIC design: Double-trigger equity acceleration only; no ongoing cash severance multiple for Richards in the current framework, limiting windfall risk .
  • Say-on-pay signal: 78% support in 2024 (below prior 3-year average of 99%); committee enhanced disclosures; context cited that 2023 TSR headwinds impacted vote .

Investment Implications

  • Alignment: Time-based RSAs with multi-year vesting and strict anti-pledging/ownership rules support alignment; absence of formulaic pay tied to EPS/NIM for the CRO reduces incentives for pro-cyclical risk-taking .
  • Retention risk: Four-year vesting cadence (2026–2029) and regular RSA grants support retention; lack of cash severance multiple reduces parachute value and could increase external poaching risk in a tight CRO talent market .
  • Trading/overhang: Known vesting tranches (9.5k in 2026; 6.5k in 2027; 3.25k in 2028; plus 3.375k annually 2026–2029 from new grant) create predictable potential supply; mitigated by ownership policy restricting sales below guideline levels .
  • Execution: 2024 performance gains in profitability and funding mix occurred alongside CRO’s risk oversight and asset quality focus, a constructive signal for continued disciplined growth .

Citations

  • Executive biography, age, education, roles:
  • Company 2024 performance metrics:
  • Base salary table and no changes:
  • Summary Compensation Table (2022–2024):
  • CRO incentive structure and 2024 criteria/award:
  • 2024 Grants of Plan-Based Awards (13,000 RSAs):
  • RSA vesting terms and outstanding awards (31,750 at FY-end; schedule):
  • 2024 vested shares/value:
  • 2025 CRO RSA grant (13,500; vest 2026–2029):
  • Beneficial ownership (2025/2024): ; record-date shares outstanding:
  • Ownership policy, compliance; anti-hedging/pledging; clawback:
  • CIC treatment and potential payments table:
  • Historical Richards CIC agreement (2018 hire window):
  • No defined benefit plans:
  • Deferred comp non-participation:
  • Say-on-pay/engagement: